Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Biology of the Cell|October 12, 2007
Type Igamma PIP kinase is a novel uropod component that regulates rear retraction during neutrophil chemotaxisMary A Lokuta, Melissa A Senetar, David A Bennin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2009
Erythrocyte scaffolding protein p55/MPP1 functions as an essential regulator of neutrophil polarityBrendan J Quinn, Emily J Welch, Anthony C Kim, et al.
Advances in Wound Care|February 15, 2014
Clinical Evaluation of NIKS-Based Bioengineered Skin Substitute Tissue in Complex Skin Defects: Phase I/IIa Clinical Trial ResultsMichael J Schurr, Kevin N Foster, Mary A Lokuta, et al.
The Journal of Trauma|March 12, 2009
Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substituteMichael J Schurr, Kevin N Foster, John M Centanni, et al.
Annals of Surgery|April 9, 2011
StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trialJohn M Centanni, Joely A Straseski, April Wicks, et al.
Burns : Journal of the International Society for Burn Injuries|August 17, 2019
An open-label, prospective, randomized, controlled, multicenter, phase 1b study of StrataGraft skin tissue versus autografting in patients with deep partial-thickness thermal burnsJames H Holmes, Michael J Schurr, Booker T King, et al.
Burns : Journal of the International Society for Burn Injuries|June 8, 2021
A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burnsAngela L F Gibson, James H Holmes, Jeffrey W Shupp, et al.
Pageof 2